@ARTICLE{
author={Stanimirovic Violeta V,Nikolic Dejan V,Nikolic Aleksandra T,Stanimitovic B,Stanimirovic B},
year={2013},
title={Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims},
journal={PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY},
volume={},
number={},
pages={177-180},
document_type={Proceedings Paper},
} 

@ARTICLE{
author={Stanimirovic Violeta V,Nikolic Dejan V,Nikolic Aleksandra T,Stanimitovic B,Stanimirovic B},
year={2013},
title={"Regulatory dilemma" of ongoing safety review of drug Gilenya (R) (fingolimod)-expierence from Medicines and Medical Devices Agency of Serbia-ALIMS},
journal={PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY},
volume={},
number={},
pages={169-171},
document_type={Proceedings Paper},
} 

